[Retracted] High CHAF1A Expression Levels Are Positively-Correlated with PD-L1 Expression and Indicate Poor Prognosis in Gastric Cancer

Table 1

Participants characteristic.

Clinicopathological features	Number (%)
Age (year)	61 (28,86)
Gender
Male	102 (72.9%)
Female	38 (27.1%)
Family history (gastric cancer)
Yes	21 (15%)
No	119 (85%)
Smoking history
Yes	50 (35.7%)
No	90 (64.3%)
Drinking history
Yes	35 (25%)
No	105 (75%)
Weight lose
Yes	53 (37.9)
No	87 (62.1%)
Tumor location
Proximal	47 (33.6%)
Distal	86 (61.4%)
Unknown	7 (5%)
Borrmann type
I	3 (2.1%)
II	76 (54.3%)
III	43 (30.7%)
IV	16 (11.4%)
Unknown	2 (1.4%)
Lauren type
Intestinal	67 (47.9%)
Diffuse	51 (21.4%)
Mixed	21 (15%)
Unknown	1 (0.7%)
Tumor size (cm)
≥ 5	89 (63.6%)
< 5	50 (35.7%)
Unknown	1 (0.7%)
Grade of differentiation
Poor	63 (45%)
Moderate-poor	49 (35%)
Moderate	21 (15%)
Well	1 (0.7%)
Unknown	6 (4.3%)
Pathological type
Adenocarcinoma	123 (87.9%)
Mucinous adenocarcinoma	12 (8.6%)
Signet ring cell carcinoma	5 (3.6%)
T stage
1	2 (1.4%)
2	6 (4.3%)
3	13 (9.3%)
4	119 (85%)
N stage
0	11 (7.9%)
1	31 (22.1%)
2	38 (27.1%)
3	60 (42.9%)
M Stage
0	127 (90.7%)
1	13 (9.3%)
TNM stage
I	1 (0.7%)
II	18 (12.9%)
III	108 (77.1%)
IV	13 (9.3%)
AFP (ng/ml)
≤ 8.1	131 (93.6%)
> 8.1	7 (5%)
Unknown	2 (1.4%)
CEA (ng/ml)
≤ 5	102 (72.9%)
> 5	38 (27.1%)
CA199 (U/ml)
≤ 37	96 (68.6%)
> 37	44 (31.4%)
CA724 (U/ml)
≤ 6.9	92 (65.7%)
> 6.9	32 (22.9%)
Unknown	6 (4.3%)
CA125 (U/ml)
≤ 35	129 (92.1%)
> 35	11 (7.9%)
CA50 (U/ml)
≤ 25	68 (48.57%)
> 25	19 (13.57%)
Unknown	53 (37.86%)